| Literature DB >> 30981686 |
Peter A Revill1, Francis V Chisari2, Joan M Block3, Maura Dandri4, Adam J Gehring5, Haitao Guo6, Jianming Hu7, Anna Kramvis8, Pietro Lampertico9, Harry L A Janssen10, Massimo Levrero11, Wenhui Li12, T Jake Liang13, Seng-Gee Lim14, Fengmin Lu15, M Capucine Penicaud16, John E Tavis17, Robert Thimme18, Fabien Zoulim19.
Abstract
Chronic hepatitis B virus (HBV) infection is a global public health challenge on the same scale as tuberculosis, HIV, and malaria. The International Coalition to Eliminate HBV (ICE-HBV) is a coalition of experts dedicated to accelerating the discovery of a cure for chronic hepatitis B. Following extensive consultation with more than 50 scientists from across the globe, as well as key stakeholders including people affected by HBV, we have identified gaps in our current knowledge and new strategies and tools that are required to achieve HBV cure. We believe that research must focus on the discovery of interventional strategies that will permanently reduce the number of productively infected cells or permanently silence the covalently closed circular DNA in those cells, and that will stimulate HBV-specific host immune responses which mimic spontaneous resolution of HBV infection. There is also a pressing need for the establishment of repositories of standardised HBV reagents and protocols that can be accessed by all HBV researchers throughout the world. The HBV cure research agenda outlined in this position paper will contribute markedly to the goal of eliminating HBV infection worldwide.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30981686 PMCID: PMC6732795 DOI: 10.1016/S2468-1253(19)30119-0
Source DB: PubMed Journal: Lancet Gastroenterol Hepatol